Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Role of Quantitative Measures on Dual-energy CT in the Prediction of Colorectal Adenocarcinoma

NCT04430127 is registered in ClinicalTrials.gov with Hôpital Fribourgeois as lead sponsor.

NCT NCT04430127
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04430127 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Role of Quantitative Measures on Dual-energy CT in the Prediction of Colorectal Adenocarcinoma
Lead sponsor
Hôpital Fribourgeois
Phase
Observational
Overall status
Unknown status
Start date
April 1, 2020
Completion date
December 31, 2022
Enrollment
50 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

colorectal adenocarcinoma